HAEMONETICS CORP's ticker is HAE and the CUSIP is 405024100. A total of 268 filers reported holding HAEMONETICS CORP in Q1 2020. The put-call ratio across all filers is 1.31 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $4,419,877 | +5.3% | 49,340 | +0.0% | 0.40% | +4.9% |
| Q2 2023 | $4,199,105 | -24.9% | 49,320 | -27.0% | 0.39% | -19.4% |
| Q1 2023 | $5,593,900 | +20.8% | 67,600 | +14.8% | 0.48% | +22.5% |
| Q4 2022 | $4,632,485 | +649.6% | 58,900 | +753.6% | 0.39% | +598.2% |
| Q2 2020 | $618,000 | -83.6% | 6,900 | -81.7% | 0.06% | -87.6% |
| Q1 2020 | $3,763,000 | -15.1% | 37,760 | -2.1% | 0.45% | +17.7% |
| Q4 2019 | $4,431,000 | +2.2% | 38,560 | +12.2% | 0.38% | +1.6% |
| Q3 2019 | $4,334,000 | +422.2% | 34,360 | +398.0% | 0.38% | +362.2% |
| Q2 2019 | $830,000 | +69.4% | 6,900 | +23.2% | 0.08% | +86.4% |
| Q1 2019 | $490,000 | -80.2% | 5,600 | -77.3% | 0.04% | -85.0% |
| Q4 2018 | $2,471,000 | +26.8% | 24,700 | +45.3% | 0.29% | +14.9% |
| Q3 2018 | $1,948,000 | +27.7% | 17,000 | 0.0% | 0.26% | +36.4% |
| Q2 2018 | $1,525,000 | +15.8% | 17,000 | -5.6% | 0.19% | +2.2% |
| Q1 2018 | $1,317,000 | -1.4% | 18,000 | -21.7% | 0.18% | -15.3% |
| Q4 2017 | $1,336,000 | – | 23,000 | – | 0.22% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| LGT CAPITAL PARTNERS LTD. | 1,216,059 | $64,500,000 | 1.72% |
| HEARTLAND ADVISORS INC | 406,192 | $21,544,000 | 1.26% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 200,000 | $10,608,000 | 1.22% |
| Aurora Investment Counsel | 32,149 | $1,705,000 | 1.01% |
| Endurant Capital Management LP | 73,914 | $3,920,000 | 0.95% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 135,000 | $7,160,000 | 0.82% |
| ARMISTICE CAPITAL, LLC | 872,000 | $46,251,000 | 0.76% |
| Summit Creek Advisors LLC | 131,357 | $6,967,000 | 0.70% |
| Dean Capital Management | 15,309 | $812,000 | 0.70% |
| Keene & Associates, Inc. | 11,720 | $622,000 | 0.54% |